{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:36:05Z","timestamp":1789058165782,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004697","name":"Hamadan University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ijbiomac.2022.03.146","type":"journal-article","created":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T17:30:28Z","timestamp":1648315828000},"page":"962-972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model"],"prefix":"10.1016","volume":"208","author":[{"given":"Zohreh","family":"Khorshidvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afra","family":"Khosravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Mahboobian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Larki-Harchegani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Fallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Hossein","family":"Maghsood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/vaccines9050413","article-title":"Advances in toxoplasma gondii vaccines: current strategies and challenges for vaccine development","volume":"9","author":"Chu","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0010","first-page":"20130433","article-title":"The contribution of vaccination to global health: past, present and future","volume":"369","author":"Greenwood","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0015","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1039\/C9NR08958F","article-title":"Nanoparticle formulated vaccines: opportunities and challenges","volume":"12","author":"Lung","year":"2020","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0020","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.chom.2020.04.003","article-title":"Engineering the live-attenuated polio vaccine to prevent reversion to virulence","volume":"13","author":"Te Yeh","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.21775\/cimb.022.079","article-title":"DNA vaccines: regulatory considerations and safety aspects","volume":"22","author":"Myhr","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0030","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.2174\/0929867326666190227192527","article-title":"Quaternized chitosan nanoparticles in vaccine applications","volume":"27","author":"Yu","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0035","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/1459394","article-title":"Adjuvants: classification, Modus operandi, and licensing","volume":"6","author":"Apost\u00f3lico","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0045","first-page":"239","article-title":"Role of metallic nanoparticles in vaccinology: implications for infectious disease vaccine development","volume":"8","author":"Kipnis","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.03.146_bb0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3390\/vaccines3020320","article-title":"Vaccine adjuvants: from 1920 to 2015 and beyond","volume":"3","author":"Pasquale","year":"2015","journal-title":"Vaccines."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0055","doi-asserted-by":"crossref","first-page":"7959","DOI":"10.2147\/IJN.S165876","article-title":"Novel application of trimethyl chitosan as an adjuvant in vaccine delivery","volume":"13","author":"Malik","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0060","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ijbiomac.2017.07.076","article-title":"Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani","volume":"105","author":"Tripathi","year":"2017","journal-title":"International Journal of Biological Macromolecules"},{"issue":"18","key":"10.1016\/j.ijbiomac.2022.03.146_bb0065","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1016\/j.biomaterials.2013.02.028","article-title":"Genipin-cross-linked fucose-chitosan\/heparin nanoparticles for the eradication of helicobacter pylori","volume":"34","author":"Lin","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0070","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejpb.2012.04.007","article-title":"Chitosan-based drug delivery systems","volume":"81","author":"Bernkop-Schn\u00fcrch","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.03.146_bb0075","first-page":"1","article-title":"The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses","volume":"42","author":"Andres","year":"2012","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.03.146_bb0080","first-page":"1061","article-title":"Evaluation of Th17 associated antigen in Old World cutaneous leishmaniasis: a comparative study in acute versus chronic human cutaneous leishmaniasis using immunohistochemistry","volume":"36","author":"Mortazavi","year":"2019","journal-title":"Trop. Biomed."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1021\/acs.molpharmaceut.7b00730","article-title":"Adjuvant activity of poly-e-caprolactone\/Chitosan nanoparticles characterized by mast cell activation and IFN-\u03b3 and IL-17 production","volume":"15","author":"Jesus","year":"2018","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jconrel.2004.08.010","article-title":"Recent advances on chitosan-based micro- and nanoparticles in drug delivery","volume":"100","author":"Agnihotri","year":"2004","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.03.146_bb0095","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1128\/CDLI.7.5.719-723.2000","article-title":"Detection and function of opioid receptors on cells from the immune system","volume":"7","author":"Bidlack","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0100","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3389\/fmicb.2016.00970","article-title":"Opioids and viral infections: a double-edged sword","volume":"7","author":"Tahamtan","year":"2016","journal-title":"Front. Microbiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.03.146_bb0105","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2249.1998.00680.x","article-title":"Endogenous opioids modulate all ograft rejection on time in mice: possible relation with Th1\/Th2 cytokines","volume":"113","author":"Sacerdote","year":"1998","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0110","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/j.1749-6632.2000.tb05440.x","article-title":"The opioid antagonist Naloxone induces a shift from type 2 to type1cytokine pattern in normal and skin-grafted mice","volume":"917","author":"Sacerdote","year":"2000","journal-title":"Ann.N.Y.Acad.Sci."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.exppara.2016.01.001","article-title":"Mixture of alum\u2013naloxone and alum\u2013naltrexone as a novel adjuvant elicits immune responses for toxoplasma gondii lysate antigen in BALB\/c mice","volume":"162","author":"Khorshidvand","year":"2016","journal-title":"Exp. Parasitol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.03.146_bb0120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.14202\/vetworld.2017.1063-1065","article-title":"Detection of anti-T. gondii antibodies in chronic myeloid leukemia and acute myeloid leukemia patients","volume":"10","author":"Gharavi","year":"2017","journal-title":"Vet. World"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0125","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2174\/1568026618666181002113617","article-title":"Treatment of toxoplasmosis and neosporosis in farm ruminants: state of knowledge and future trends","volume":"18","author":"S\u00e1nchez-S\u00e1nchez","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1756-3305-7-180","article-title":"Research progress on surface antigen 1 (SAG1) of toxoplasma gondii","volume":"7","author":"Yanhua","year":"2014","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.micpath.2018.11.003","article-title":"A systematic review of toxoplasma gondii antigens to find the best vaccine candidates for immunization","volume":"126","author":"Rezaei","year":"2018","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.03.146_bb0140","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1590\/S0074-02762009000200019","article-title":"Vaccines against Toxoplasma gondii: challenges and opportunities","volume":"104","author":"Jongert","year":"2009","journal-title":"Mem Inst Oswaldo Cruz, Rio de Janeiro"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jim.2014.11.012","article-title":"Production of in-vitro refolded and highly antigenic SAG1 for development of a sensitive and specific toxoplasma IgG ELISA","volume":"416","author":"Allahyari","year":"2015","journal-title":"J. Immunol. Methods"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.03.146_bb0150","doi-asserted-by":"crossref","first-page":"632","DOI":"10.15171\/apb.2019.073","article-title":"Evaluation of immunogenic effect of Toxoplasma gondii recombinant SAG-1 antigen with propranolol as adjuvant in BALB\/c mice","volume":"9","author":"Abasi","year":"2019","journal-title":"Adv. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejpb.2003.09.006","article-title":"Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice","volume":"57","author":"Vila","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0160","first-page":"835","article-title":"Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing leishmania superoxide dismutase and evaluation of its immunogenicity in BALB\/c mice","volume":"6","author":"Danesh-Bahreini","year":"2011","journal-title":"Int. J. Nanomedicine"},{"issue":"10","key":"10.1016\/j.ijbiomac.2022.03.146_bb0165","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1021\/mp300162j","article-title":"Insight on the formation of chitosan nanoparticles through ionotropic gelation with tripolyphosphate","volume":"9","author":"Koukaras","year":"2012","journal-title":"Mol. Pharm."},{"issue":"30","key":"10.1016\/j.ijbiomac.2022.03.146_bb0170","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.vaccine.2012.02.017","article-title":"A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed salmonella typhimurium vaccine","volume":"30","author":"Mazloomi","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.03.146_bb0175","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5152\/tpd.2013.22","article-title":"A novel adjuvant, mixture of alum and naltrexone, elicits humoral immune responses for excreted\/secreted antigens of Toxoplasma gondii tachyzoites vaccine in balb\/c murine Model","volume":"37","author":"Hazrati Tappeh","year":"2013","journal-title":"Turk. Parazitol. Derg."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpb.2018.07.018","article-title":"Chitosan: \u00df-glucan particles as a new adjuvant for the hepatitis B antigen","volume":"131","author":"Soares","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.imlet.2019.01.010","article-title":"A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of brucella melitensis omp 31","volume":"207","author":"Abkar","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fcimb.2018.00163","article-title":"Chitosan microsphere used as an effective system to deliver a linked antigenic peptides vaccine protect mice against acute and chronic toxoplasmosis","volume":"23","author":"Guo","year":"2018","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0195","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2147\/IJN.S158736","article-title":"Anti-toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain","volume":"13","author":"Teimouri","year":"2018","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.03.146_bb0200","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1590\/S0104-14282009000300013","article-title":"A review of the antimicrobial activity of chitosan","volume":"19","author":"Goy","year":"2009","journal-title":"Polimeros."},{"issue":"1-2","key":"10.1016\/j.ijbiomac.2022.03.146_bb0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2018.09.044","article-title":"Mechanistic study of the adjuvant effect of chitosan-aluminum nanoparticles","volume":"552","author":"Lebrea","year":"2018","journal-title":"International Journal of Pharmaceutics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.03.146_bb0210","first-page":"165","article-title":"Chitosan-based nanoparticles in mucosal vaccine delivery","volume":"73","author":"Mehrabi","year":"2018","journal-title":"Archives of Razi Institute"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.carbpol.2016.06.096","article-title":"Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel","volume":"153","author":"Al-Kassas","year":"2016","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.03.146_bb0220","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2004.09.028","article-title":"Sustained release of lidocaine from poloxamer 407 gels","volume":"288","author":"Ricci","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.03.146_bb0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0144-8617(93)90076-G","article-title":"N-[l3C=O] acetyl chitosan and its digestibility by silk worms","volume":"22","author":"Hirano","year":"1993","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0230","first-page":"2972","article-title":"Current vaccine adjuvants: an overview of a diverse class","volume":"9","author":"Kensil","year":"2004","journal-title":"Front Bio Sci."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.03.146_bb0235","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1586\/erv.10.89","article-title":"Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses","volume":"9","author":"Oyewumi","year":"2010","journal-title":"Exp. Rev. Vac."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/mp060096p","article-title":"Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus","volume":"4","author":"Mottram","year":"2007","journal-title":"Mol. Pharmaceut."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0245","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2014.03.046","article-title":"Naltrexone: a review of existing sustained drug delivery systems and emerging nano-based systems","volume":"183","author":"Goonoo","year":"2014","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2022.03.146_bb0250","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.micinf.2010.02.001","article-title":"Evaluation of the adjuvant activity of naloxone, an opioid receptor antagonist, incombination with heat-killed listeria monocytogenes vaccine","volume":"12","author":"Jazani","year":"2010","journal-title":"Microbes Infect."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0255","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1574-695X.2010.00747.x","article-title":"A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed salmonella typhimurium vaccine","volume":"61","author":"Jazani","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0260","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/pharmaceutics12060496","article-title":"Design and characterization of spray-dried chitosan-naltrexone microspheres for microneedle-assisted transdermal delivery","volume":"12","author":"Ogunjimi","year":"2020","journal-title":"Pharmaceutics."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.03.146_bb0265","first-page":"530","article-title":"Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice","volume":"22","author":"He","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0270","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jconrel.2017.03.396","article-title":"Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres","volume":"255","author":"Andhariya","year":"2017","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2022.03.146_bb0275","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0378-5173(02)00297-1","article-title":"Design of naltrexone-loaded hydrolyze able crosslinked nanoparticles","volume":"244","author":"Yin","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0280","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.exppara.2016.09.008","article-title":"Synergistic effect of rSAG1 and rGRA2 antigens formulated in PLGA microspheres in eliciting immune protection against toxoplasama gondii","volume":"170","author":"Allahyari","year":"2016","journal-title":"Exp. Parasitol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2022.03.146_bb0285","doi-asserted-by":"crossref","first-page":"8178","DOI":"10.1021\/la060951b","article-title":"Macrophage uptake of core-shell nanoparticles surface modified with poly (ethylene glycol)","volume":"22","author":"Zahr","year":"2006","journal-title":"Langmuir"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101414","article-title":"Toxoplasma gondii surface antigen 1 (SAG1) as a potential candidate to develop vaccine against toxoplasmosis: a systematic review","volume":"69","author":"Pagheh","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0295","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fmicb.2017.00216","article-title":"Immuno efficacy of a T. gondii secreted protein with an altered thrombospondin repeat (Tgspatr) as a novel DNA vaccine candidate against acute toxoplasmosis in Balb\/C mice","volume":"8","author":"Zheng","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev-chembioeng-080615-034446","article-title":"Nanoparticle-based modulation of the immune system","volume":"7","author":"Fang","year":"2016","journal-title":"Annu. Rev. Chem. Bio mol. Eng."},{"issue":"7","key":"10.1016\/j.ijbiomac.2022.03.146_bb0305","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1586\/erv.09.47","article-title":"Chitosan-based systems for the delivery of vaccine antigens","volume":"8","author":"Arca","year":"2009","journal-title":"Expert Rev. Vaccines."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.03.146_bb0310","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.4161\/hv.26136","article-title":"Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses","volume":"9","author":"Joshi","year":"2013","journal-title":"Hum. Vaccines Immunol. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2022.03.146_bb0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.7774\/cevr.2015.4.1.23","article-title":"Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes","volume":"4","author":"Powell","year":"2015","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0320","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejpb.2015.03.024","article-title":"Development of a novel adjuvanted nasal vaccine: C48\/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity","volume":"93","author":"Bento","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.03.146_bb0325","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1211\/jpp.60.12.0004","article-title":"Comparison of chitosan nanoparticles and chitosan hydrogels for vaccine delivery","volume":"60","author":"Gordon","year":"2008","journal-title":"Journal of Pharmacy and Pharmacology."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0330","doi-asserted-by":"crossref","first-page":"808","DOI":"10.3389\/fmicb.2016.00808","article-title":"Induction of protective immunity against toxoplasmosis in Balb\/C mice vaccinated with toxoplasma gondii Rhoptry-1","volume":"7","author":"Sonaimuthu","year":"2016","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2022.03.146_bb0335","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2217\/imt.11.68","article-title":"The CD8 T-cell road to immunotherapy of toxoplasmosis","volume":"3","author":"Bhadra","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0340","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.biomaterials.2015.01.056","article-title":"Porous nanoparticles as delivery system of complex antigens for an effective vaccine against acute and chronic toxoplasma gondii infection","volume":"50","author":"Dimier-Poisson","year":"2015","journal-title":"Biomaterials"},{"issue":"47","key":"10.1016\/j.ijbiomac.2022.03.146_bb0345","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1016\/j.vaccine.2014.09.024","article-title":"HBHA vaccination may require both Th1 and Th17 immune responses to protect mice against tuberculosis","volume":"32","author":"Verwaerde","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2022.03.146_bb0350","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the development of anti-toxoplasma gondii vaccines: challengesOpportunities, and Perspectives","volume":"35","author":"Wang","year":"2019","journal-title":"Trends Parasitol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2022.03.146_bb0355","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.vaccine.2018.01.051","article-title":"Identification of suitable adjuvant for vaccine formulation with the Neospora caninum antigen NcSRS2","volume":"36","author":"Pinheiro","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ijbiomac.2022.03.146_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0000604","article-title":"IL-17 Produced during Trypanosoma cruzi infection plays a central role in regulating parasite-induced myocarditis","volume":"4","author":"Guedes","year":"2010","journal-title":"PLOS Neglected Tropical Diseas"},{"issue":"4","key":"10.1016\/j.ijbiomac.2022.03.146_bb0365","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijbiomac.2022.03.146_bb0370","first-page":"71","article-title":"Immune response to toxoplasma gondii","volume":"40","author":"Filisetti","year":"2004","journal-title":"Ann Ist Super Sanita"},{"issue":"12","key":"10.1016\/j.ijbiomac.2022.03.146_bb0375","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-3024.2007.00982.x","article-title":"Congenital and acquired toxoplasmosis: diversity and role of antibodies in different compartments of the host","volume":"29","author":"Correa","year":"2007","journal-title":"Parasite Immunol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302200616X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302200616X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:39:20Z","timestamp":1758879560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302200616X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":75,"alternative-id":["S014181302200616X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.03.146","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.03.146","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}